It has always been the case that Recce's unique method of action would be effective against both enveloped viruses and bacteria, as it exploits the same vulnerability shared by both organisms. There is nothing "sudden" about this.
Since they announced this was happening back in July 2020, why has it taken you this long to ask these questions?
These COVID trials are a sideshow, and nothing to get overly excited about: The main story is, and remains, about Sepsis. Nothing has changed.
RCE Price at posting:
$1.05 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)